Visit Our Booth - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Visit Our Booth


Seamlessly progress from R&D to large scale production with Eppendorf’s DASGIP® and New Brunswick™ bioprocessing systems and software solutions. Single or parallel systems with working volumes from 35 mL to 2500 L. Eppendorf’s renowned expertise in plastics manufacturing produces high quality singleuse vessels from 100 mL up to 40 L working volumes.

Eppendorf, Hauppauge, NY
eppendorf.com • tel. 800.645.3050
INTERPHEX Booth # 3738

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here